Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Onchocerciasis].

C D Enk1, K Gardlo, T Ruzicka

  • 1The Hadassah-Germany Skin Center, Department of Dermatology, The Hebrew University Medical School, Jerusalem, Israel. enk@hadassah.org.il

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life experience in the treatment of solar urticaria: retrospective cohort study.

Clinical and experimental dermatology·2019
Same author

Integrated cooling-vacuum-assisted 1540-nm erbium:glass laser is effective in treating mild-to-moderate acne vulgaris.

Lasers in medical science·2015
Same author

Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2015
Same author

Noninvasive in vivo confocal laser scanning microscopy is effective in differentiating allergic from nonallergic equivocal patch test reactions.

Lasers in medical science·2015
Same author

Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modality.

The British journal of dermatology·2014
Same author

Late-onset onchocercal skin disease among Ethiopian immigrants.

The British journal of dermatology·2014
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Onchocerciasis, a parasitic worm infestation, causes severe itching and skin/eye problems. Ivermectin is the primary treatment for this disease spread by blackflies in tropical regions.

Area of Science:

  • Medical Parasitology
  • Tropical Medicine
  • Public Health

Context:

  • Onchocerciasis, caused by Onchocerca volvulus, is a significant health issue in Africa, Arabia, and the Americas.
  • Spread by blackfly bites, it leads to debilitating skin lesions, intense itching, and potentially blindness.
  • Current mass treatment programs offer partial control but do not eliminate the disease.

Purpose:

  • To provide a comprehensive overview of onchocerciasis, including its causative agent, transmission, clinical manifestations, and diagnostic methods.
  • To highlight the current treatment strategies and the role of ivermectin in managing the disease.

Summary:

  • Onchocerciasis is a parasitic nematode infection characterized by pruritus, dermatitis, hypopigmentation, and ocular disease, including blindness.

Related Experiment Videos

  • Diagnosis involves skin snips to visualize larvae or slit-lamp examination for microfilariae in the anterior chamber.
  • Ivermectin is the drug of choice, demonstrating high efficacy against microfilariae for both cutaneous and ocular onchocerciasis.

    • Impact:

    • Improved understanding of onchocerciasis pathogenesis and clinical presentation.
    • Reinforces the importance of ivermectin in onchocerciasis control programs.
    • Highlights the ongoing public health challenge posed by onchocerciasis in endemic areas.